Abstract
Human serum albumin (HSA) is a major plasma protein and binding of drugs with this plasma protein has a great importance. It possess esterase activity which can cleave the drugs containing ester bond and thus, can regulate the effect of drugs. Till date no systematic study has been done to analyse binding of such drugs and to compare the results with the drugs which do not have ester bond. Therefore, in the present study two different categories—ester and non-ester drugs have been considered to analyse their interaction with HSA at two principle drug binding sites using molecular modelling tools. It is observed that the drugs irrespective of ester or non-ester nature prefer either Sudlow site I or II by hydrogen bond and hydrophobic interactions. The information obtained from the study can assist to study pharmacokinetics of the drugs and that in turn will help in noval drug discoveries.
Similar content being viewed by others
Abbreviations
- HSA:
-
Human serum albumin
- MD:
-
Molecular dynamics
- Rg:
-
Radius of gyration
- RMSD:
-
Root mean square deviation
References
Chen YC, Wang HM, Niu QX, Ye DY, Liang GW (2016) Binding between Saikosaponin C and human serum albumin by fluorescence spectroscopy and molecular docking. Molecules 21(2):153
Lambrinidis G, Vallianatou T, Tsantili-Kakoulidou A (2015) In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review. Adv Drug Deliv Rev 86:27–45
Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Prot Eng 12(6):439–446
Yang F, Bian C, Zhu L, Zhao G, Huang Z, Huang M (2007) Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin. J Struct Biol 157(2):348–355
Goncharov NV, Belinskaia DA, Shmurak VI, Terpilowski MA, Jenkins RO, Avdonin PV (2017) Serum albumin binding and esterase activity: mechanistic interactions with organophosphates. Molecules 22(7):1201
Yamasaki K, Hyodo S, Taguchi K, Nishi K, Yamaotsu N, Hirono S, Otagiri M (2017) Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. PLoS ONE 12(6):e0180404
Russell BA, Mulheran PA, Birch DJS, Chen Y (2016) Probing the Sudlow binding site with warfarin: how does gold nanocluster growth alter human serum albumin? Phys Chem Chem Phys 18(33):22874–22878
Petitpas I, Bhattacharya AA, Twine S, East M, Curry S (2001) Crystal structure analysis of warfarin binding to human serum albumin anatomy of drug site I. J Biol Chem 276(25):22804–22809
Bhattacharya AA, Curry S, Franks NP (2000) Binding of the general anestheticspropofol and halothane to human serum albumin high resolution crystal structures. J Biol Chem 275(49):38731–38738
Liu R, Meng Q, Xi J, Yang J, Ha CE, Bhagavan NV, Eckenhoff RG (2004) Comparative binding character of two general anaesthetics for sites on human serum albumin. Biochem J 380(Pt 1):147
Evoli S, Mobley DL, Guzzi R, Rizzuti B (2016) Multiple binding modes of ibuprofen in human serum albumin identified by absolute binding free energy calculations. Phys Chem Chem Phys 18(47):32358–32368
Yang F, Zhang Y, Liang H (2014) Interactive association of drugs binding to human serum albumin. Int J Mol Sci 15(3):3580–3595
Ishtikhar M, Khan MV, Khan S, Chaturvedi SK, Badr G, Mahmoud MH, Khan RH (2016) Biophysical and molecular docking insight into interaction mechanism and thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble camptothecinanalogirinotecan hydrochloride. J Biomol Struct Dyn 34(7):1545–1560
Harm S, Schildböck C, Hartmann J (2018) Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification. PLoS ONE 13(1):e0191741
Omidvar Z, Asoodeh A, Chamani J (2013) Studies on the antagonistic behavior between cyclophosphamide hydrochloride and aspirin with human serum albumin: time-resolved fluorescence spectroscopy and isothermal titration calorimetry. J Solut Chem 42(5):1005–1017
Marouzi S, Rad AS, Beigoli S, Baghaee PT, Darban RA, Chamani J (2017) Study on effect of lomefloxacin on human holo-transferrin in the presence of essential and nonessential amino acids: spectroscopic and molecular modeling approaches. Int J Biol Macromol 97:688–699
Rashidipour S, Naeeminejad S, Chamani J (2016) Study of the interaction between DNP and DIDS with human hemoglobin as binary and ternary systems: spectroscopic and molecular modeling investigation. J Biomol Struct Dyn 34(1):57–77
Hamed-Akbari Tousi S, Reza Saberi M, Chamani J (2010) Comparing the interaction of cyclophosphamide monohydrate to human serum albumin as opposed to holo-transferrin by spectroscopic and molecular modeling methods: evidence for allocating the binding site. Prot Pept Lett 17(12):1524–1535
Bozorgmehr MR, Chamani J, Moslehi G (2015) Spectroscopic and DFT investigation of interactions between cyclophosphamide and aspirin with lysozyme as binary and ternary systems. J Biomol Struct Dyn 33(8):1669–1681
Alonso H, Bliznyuk AA, Gready JE (2006) Combining docking and molecular dynamic simulations in drug design. Med Res Rev 26(5):531–568
Śledź P, Caflisch A (2018) Protein structure-based drug design: from docking to molecular dynamics. Curr Opin Struct Biol 48:93–102
Narwal M, Kumar D, Maniar K, Bhattacharyya R, Banerjee D (2018) Albumin binding: an important parameter to study for drugs with low therapeutic index. J Transl Sci 4(3):1–2
Acknowledgements
DK acknowledges Council of Scientific and Industrial Research, India for providing fellowship (File No: 09/141(0197)/2016-EMR-I).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Narwal, M., Kumar, D., Mukherjee, T.K. et al. Molecular dynamics simulation as a tool for assessment of drug binding property of human serum albumin. Mol Biol Rep 45, 1647–1652 (2018). https://doi.org/10.1007/s11033-018-4308-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-018-4308-3